Analysts UBS initiate coverage of CoreWeave (CW) with Buy rating and $120 target price (upside +40%)
Several analysts have made significant calls on various companies, highlighting growth potential in sectors such as AI infrastructure, healthcare, and pharmaceuticals, which could influence investor sentiment and stock performance.